Viewing Study NCT00627068


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-03-01 @ 10:08 AM
Study NCT ID: NCT00627068
Status: COMPLETED
Last Update Posted: 2011-09-20
First Post: 2008-02-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Role of Nitric Oxide Synthase in Circulating Progenitor Cell Function
Sponsor: University of California, San Francisco
Organization:

Study Overview

Official Title: The Role of Nitric Oxide Synthase in Circulating Progenitor Cell Function
Status: COMPLETED
Status Verified Date: 2011-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Our main hypothesis is that EPC function is impaired in some populations with high cardiovascular risk as a result of reduced eNOS-dependent NO production.
Detailed Description: To determine if a correlation exists between EPC function and eNOS-dependent NO production in EPCs from populations with high versus low cardiovascular risk:

1. High and low cardiovascular risk subjects will be identified based on age or history of cardiovascular disease. Endothelial function will be measured by ultrasound.
2. EPCs will be isolated from peripheral blood of these subjects. EPC function will be assessed by measuring adhesion to endothelium, migration, proliferation, and differentiation, and compared to their expression and activity of eNOS.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: